Yazar, A. 2017. Cytolitic tests with hyperimmune patient sera is a good prognostic tool in racotumomab immunotherapy in advanced non-small cell lung cancer. advances in modern oncology research , vol.3, no.5 , 223-231.

Yazar, A., (2017). Cytolitic tests with hyperimmune patient sera is a good prognostic tool in racotumomab immunotherapy in advanced non-small cell lung cancer. advances in modern oncology research , vol.3, no.5, 223-231.

Yazar, AZİZ. "Cytolitic tests with hyperimmune patient sera is a good prognostic tool in racotumomab immunotherapy in advanced non-small cell lung cancer," advances in modern oncology research , vol.3, no.5, 223-231, 2017

Yazar, AZİZ. "Cytolitic tests with hyperimmune patient sera is a good prognostic tool in racotumomab immunotherapy in advanced non-small cell lung cancer." advances in modern oncology research , vol.3, no.5, pp.223-231, 2017

Yazar, A. (2017) . "Cytolitic tests with hyperimmune patient sera is a good prognostic tool in racotumomab immunotherapy in advanced non-small cell lung cancer." advances in modern oncology research , vol.3, no.5, pp.223-231.

@article{article, author={AZİZ YAZAR}, title={Cytolitic tests with hyperimmune patient sera is a good prognostic tool in racotumomab immunotherapy in advanced non-small cell lung cancer}, journal={advances in modern oncology research}, year=2017, pages={223-231} }